Trade Summary

3 months ago, Paul Steven M, serving as Dir at Rapport Therapeutics, Inc. (RAPP), purchased 41,666 shares at $24.65 per share, for a total transaction value of $1,027,111.00. Following this transaction, Paul Steven M now holds 41,666 shares of RAPP.

The trade was executed on Friday, September 12, 2025 and publicly disclosed via SEC Form 4 filing on Monday, September 15, 2025, 3 days after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.